These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 669855)

  • 41. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

  • 42. Cure of a mouse lymphoma with radio-iodinated antibody.
    Ghose T; Guclu A
    Eur J Cancer (1965); 1974 Dec; 10(12):787-92. PubMed ID: 4461282
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemotherapy of murine ovarian carcinoma by methotrexate-antibody conjugates.
    Burstein S; Knapp R
    J Med Chem; 1977 Jul; 20(7):950-2. PubMed ID: 69028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin.
    Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Biochem Biophys; 1976 May; 1(4):197-202. PubMed ID: 975021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasound triggered release of cisplatin from liposomes in murine tumors.
    Schroeder A; Honen R; Turjeman K; Gabizon A; Kost J; Barenholz Y
    J Control Release; 2009 Jul; 137(1):63-8. PubMed ID: 19303426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cytostatic action of semisynthetic rubomycin derivatives].
    Volkolupova OP; Makukho LV
    Antibiotiki; 1982 Oct; 27(10):779-81. PubMed ID: 7149685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regression.
    Masztalerz A; Van Rooijen N; Den Otter W; Everse LA
    Cancer Immunol Immunother; 2003 Apr; 52(4):235-42. PubMed ID: 12669248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. THE GROWTH OF MURINE LYMPHOMATOUS TUMOUR-CELLS AS DETERMINED BY HOST SURVIVAL-TIME.
    MARUYAMA Y; BROWN BW
    Int J Radiat Biol Relat Stud Phys Chem Med; 1964; 8():59-73. PubMed ID: 14190708
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of immunization on the spread of transplanted mouse lymphoma cells.
    Klein E
    J Natl Cancer Inst; 1973 Dec; 51(6):1991-2. PubMed ID: 4587755
    [No Abstract]   [Full Text] [Related]  

  • 50. Changes in cell surface properties during the in vivo growth of Moloney lymphoma.
    Fenyö EM; Peebles PT; Wahlström A; Klein E; Cochran AJ
    Isr J Med Sci; 1973 Mar; 9(3):239-50. PubMed ID: 4575651
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic evaluation of liposome-encapsulated Daunoblastin in murine tumor models.
    Fichtner I; Reszka R; Elbe B; Arndt D
    Neoplasma; 1981; 28(2):141-9. PubMed ID: 7254432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

  • 54. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of murine plasmocytoma tumours with antibody activity by their respective specific antigens.
    Paraf A; Guérin-Marchand C; Aubry J; Dubert JM
    Ann Immunol (Paris); 1975; 126C(4):411-21. PubMed ID: 55094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the mechanism of action of the tumour inhibitory triazenes.
    Audette RC; Connors TA; Mandel HG; Merai K; Ross WC
    Biochem Pharmacol; 1973 Aug; 22(15):1855-64. PubMed ID: 4722457
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.
    Tsukada Y; Hurwitz E; Kashi R; Sela M; Hibi N; Hara A; Hirai H
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7896-9. PubMed ID: 6185954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunochemotherapy of cancer with chlorambucil-carrying antibody.
    Ghose T; Norvell ST; Guclu A; Cameron D; Bodurtha A; MacDonald AS
    Br Med J; 1972 Aug; 3(5825):495-9. PubMed ID: 4560726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of cancer cell kill by chemotherapeutic agents in vivo.
    Wilcox WS
    Natl Cancer Inst Monogr; 1967 Feb; 24():257-69. PubMed ID: 6021080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.